Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats

Journal Article · · Journal of Bone and Mineral Research
; ; ;
Abstract

Prostaglandin E2 (PGE2) has been recognized for its marked anabolic effect on bone, but the bone gain is lost after the cessation of PGE2 treatment. In previous studies, we were successful in maintaining the new bone by administering a bisphosphonate after the withdrawal of PGE2 treatment. The objective of this study was to determine the fate of the extra bone induced by a combination with PGE2 and risedronate after discontinuing treatment. Ninety-six 9-month-old virgin female Sprague-Dawley rats were treated with 1 or 5 μg of risedronate/ kg/twice weekly, 6 mg of PGE2/kg/day alone or 6 mg of PGE2/kg/day plus 1 or 5 μg of risedronate/kg/twice weekly for 60 days (day 0) and followed by 60 days without treatment (day 60). We have reported the results from the groups treated for 60 days previously. This report is restricted to the histomorphometric findings on the secondary spongiosa of the proximal tibial metaphysis in the groups after withdrawal for 60 days. We found that the only group that maintained the PGE2 induced new bone after withdrawal was the group treated with 6 mg of PGE2/kg/day plus 5 μg of risedronate/kg/twice a week. Withdrawal of this combined treatment depressed bone turnover (bone-based bone formation rate, activation frequency) and bone resorption (percent eroded perimeter). The tissue mechanisms responsible for the protection drew from the previously deposited risedronate.

Sponsoring Organization:
USDOE
OSTI ID:
2283121
Journal Information:
Journal of Bone and Mineral Research, Journal Name: Journal of Bone and Mineral Research Journal Issue: 6 Vol. 10; ISSN 0884-0431
Publisher:
Oxford University PressCopyright Statement
Country of Publication:
United States
Language:
English

References (22)

Bone ?mass? and the ?mechanostat?: A proposal journal September 1987
Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff's Law: The bone modeling problem journal April 1990
Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff's Law: The remodeling problem journal April 1990
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee journal December 1987
Perspectives: The role of changes in mechanical usage set points in the pathogenesis of osteoporosis journal March 1992
Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure journal September 1992
Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats journal July 1993
Effects of long-term daily administration of prostaglandin-E2 on maintaining elevated proximal tibial metaphyseal cancellous bone mass in male rats journal March 1992
Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats journal September 1993
Cell kinetics and morphology of the growth plate in the normal and hypophysectomized rat journal December 1973
A quantitative histologic analysis of the growing long bone metaphysis journal December 1980
Loss of prostaglandin E2-induced extra cortical bone after its withdrawal in rats journal April 1992
Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats journal October 1992
Partial loss of anabolic effect of prostaglandin E2 on bone after its withdrawal in rats journal January 1991
Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: Dynamic histomorphometry of changes in bone mass journal May 1993
Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats journal September 1994
Bone Response to Termination of ŒStrogen Treatment journal June 1978
Bone mass in Postmenopausal Women After Withdrawal of Oestrogen/Gestagen Replacement Therapy journal February 1981
Maintenance of bone mass by physical exercise after discontinuation of intermittent hPTH(1–34) administration journal December 1993
A Determinant of Bone Architecture journal May 1983
Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. journal February 1993
The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats. journal May 1994

Similar Records

Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure
Journal Article · Mon Aug 31 20:00:00 EDT 1992 · Journal of Bone and Mineral Research · OSTI ID:2283092
Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1–38) in right hindlimb immobilized rats
Journal Article · Tue Oct 31 19:00:00 EST 1995 · Journal of Bone and Mineral Research · OSTI ID:2283130
Prolonged Treatments With Antiresorptive Agents and PTH Have Different Effects on Bone Strength and the Degree of Mineralization in Old Estrogen-Deficient Osteoporotic Rats
Journal Article · Thu Dec 03 23:00:00 EST 2009 · Journal of Bone and Mineral Research · OSTI ID:1627117

Related Subjects